Eng J. .1990 .Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom. The Journal of Biological Chemistry, 265(33) : 20259-20262.
Eng J. .1992 .Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. The Journal of Biological Chemistry, 267(11) : 7402-7405.
Figat M. . .Beneficial influence of exendin-4 on specific organs and mechanisms favourable for the elderly with concomitant obstructive lung diseases. Brain Sciences, 12(2022) : 1090.
Yap M.K.K ,Misuan N. . .Exendin-4 from Heloderma suspectum venom: from discovery to its latest application as type II diabetes combatant. ” Basic & Clinical Pharmacology & Toxicology, 124(2019) : 513-527.
Chung C.H. .2024 .RETRACTED: Long-lasting exendin-4- loaded PLGA nanoparticles ameliorate cerebral ischemia/reperfusion damage in diabetic rats. ” Journal of Personalized Medicine, 12(2022) : 390.
Fu X. . .Dermatologic implications of glucagon-like peptide-1 receptor agonist medications. ” Skin Appendage Disorders, 11(2025) : 1-8.
Iwaya C. .2017 .Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-κB activation. ” Endocrinology, 158(12) : 4218-4228.
Faurschou S. . .GLP-1RAs in patients with psoriasis. International Journal of Molecular Sciences, 26(2025) : 3396.
Samotij D. . .Pathogenesis of psoriasis in the 'omic' era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances. ” Postepy Dermatologii i Alergologii, 37(2020) : 135-153.
Buysschaert M. .2010 .Improvement of psoriasis during exenatide treatment in a patient with diabetes. ” Diabetes Care, 33(11) : e135.
Hogan A.E. .2011 .Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. ” Diabetologia, 54(10) : 2664-2674.
Lin H. . .Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes.” Experimental and Therapeutic Medicine. , 12(2016) : 3907-3912.
Burgess J.L. .2021 .Diabetic wound-healing science. ” Medicina (Kaunas), 57(10) : 1072.
Monroy L. .1871 .Effects of exendin-4 on diabetic wounds: direct action on proliferative phase of wound healing. ” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, (2025) : 166946.
Hao H. .2017 .Exendin-4 in combination with adiposederived stem cells promotes angiogenesis and improves diabetic wound healing. ” Journal of Surgical Research, 212 : 19-28.
Sun Y. .2017 .Exendin-4 exhibits enhanced anti-tumor effects in diabetic mice. ” EBioMedicine, 19 : 130-139.